Newling, D W <br/><br/>
Second-line treatment of metastatic prostatic carcinoma.  [electronic resource] 

 -  Urological research  1997 
 - S73-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0300-5623 
<br/><br/><label>Standard No.: </label>10.1007/BF00941992  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Cell Differentiation--drug effects<br/>Combined Modality Therapy<br/>Growth Inhibitors--therapeutic use<br/>Humans<br/>Male<br/>Neoplasms, Hormone-Dependent--immunology<br/>Palliative Care<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--immunology<br/>Quality of Life